11 years ago
FDA approves Boehringer drug to treat advanced lung cancer
The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation.
Continue Reading
http://www.reuters.com
Join the Discussion